Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1128377

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage men to get tested for prostate cancer.
	tabling member constituency	Upper Bann
	tabling member printed	David Simpson
	uin	257491
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>There are risks and benefits ‎of testing for prostate cancer. There are side effects to many of the treatments for prostate cancer, such as impotence and incontinence, but, there is no doubt that, in some cases, if found early, ‎it could save lives. However, many of the men having tests and receiving treatment would not have any symptoms or problems relating to their cancers in their life.</p><p>The Prostate Cancer Risk Management Programme (PCRMP) supports men in making an informed choice on whether to be tested for prostate cancer. The PCRMP provides general practitioners and primary care professionals with information to counsel asymptomatic men aged 50 and over who ask about prostate specific antigen testing for prostate cancer.</p><p>Further information on the PCRMP is available at the following link:</p><p><a href="https://www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview" target="_blank">https://www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:16:14 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1597 label Biography information for David Simpson

1128378

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much Government funding was allocated to NHS orthodontist services in each of the last three years.
	tabling member constituency	Upper Bann
	tabling member printed	David Simpson
	uin	257492
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>Information on funding allocations for National Health Service orthodontist services is not available. NHS England is responsible for determining funding allocations for NHS dentistry. These allocations are included in the primary care allocations made to NHS regional teams. However, NHS England does not allocate funding specifically for NHS orthodontics. Data on NHS orthodontics expenditure is not held centrally.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:14:46 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1597 label Biography information for David Simpson

1129616

	registered interest
	date	04/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Food Standards Agency: Powers
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what additional powers he plans to confer on the Food Standards Agency after the UK leaves the EU.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	259843
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>Decisions about what additional powers could be transferred to the Food Standards Agency after the United Kingdom leaves the European Union would be subject to consultation. We need to understand the nature of the decisions further before setting out which powers can be delegated. Decisions would sit with Ministers in the first instance while routine and technical ones would be delegated later.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 15:55:51 answering member 4455 label Biography information for Seema Kennedy
	tabling member	252 label Biography information for Dr David Drew

1129624

	registered interest
	date	04/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Food: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress he has made on implementing the regulating our future programme in relation to food standards; and whether the implementation of that programme requires legislative change.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	259845
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>Since December, good progress has been made to develop proposals and an update on these will be presented at the next meeting of the Food Standards Agency (FSA) Board on 19 June 2019. This will advise on the progress to date and the plans to implement a modernised food standards delivery model over the next two years. The Board Paper has been published on the FSA’s website ahead of the meeting and is available at the following link:</p><p> </p><p><a href="https://www.food.gov.uk/sites/default/files/media/document/fsa-19-06-06-regulating-our-future-rof-delivering-a-modernised-model-for-food-standards-official-controls.pdf" target="_blank">https://www.food.gov.uk/sites/default/files/media/document/fsa-19-06-06-regulating-our-future-rof-delivering-a-modernised-model-for-food-standards-official-controls.pdf</a></p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 16:19:08 answering member 4455 label Biography information for Seema Kennedy
	tabling member	252 label Biography information for Dr David Drew

1129995

	registered interest
	date	05/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timeframe is for the roll-out of the national screening programme for cancer; and how many patients will initially be included in that programme.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	260532
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>The National Health Service provides three national cancer population-based screening programmes as part of the Section 7a Public Health services, commissioned by NHS England on behalf of the Secretary of State.</p><p>During 2018, the NHS screened 3.2 million women for cervical abnormalities; 2.6 million people for bowel cancer; and 2.1 million women for breast cancer.</p><p>The NHS Long Term Plan commits to modernising the Bowel Cancer screening programme to detect more cancers earlier by lowering the starting age for bowel screening from 60 to 50 over time and replacing the guaiac Faecal Occult Blood Test kit with the more sensitive Faecal Immunochemical Test for haemoglobin from summer 2019. It also confirmed that using human papillomavirus testing as the primary screen for cervical cancer will be implemented across England by 2020.</p><p><strong><em> </em></strong></p><p><strong><em> </em></strong></p><p><strong><em> </em></strong></p><p><strong><em> </em></strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 16:16:17 answering member 4455 label Biography information for Seema Kennedy
	tabling member	252 label Biography information for Dr David Drew

1129996

	registered interest
	date	05/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to tackle the decline in the number of women taking up (a) breast and (b) cervical cancer screening.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	260533
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>Professor Sir Mike Richards has published his interim independent review of national cancer screening programmes in England.</p><p>The interim report makes two recommendations: that local systems across the country take immediate action to address the decline in screening uptake by implementing interventions for which a clear evidence base already exists; and that national stakeholders should ensure IT systems for general practitioner registrations and screening are fit for purpose.</p><p>The report notes that in order to encourage uptake in harder to reach groups, the Government needs to build the evidence base for other emerging interventions, paying particular attention to novel approaches that have been introduced locally and appear to be successful. Evaluation would be needed to determine whether they can be replicated on a wider scale. Professor Sir Mike Richards has committed to gathering further evidence on these and other interventions as the review progresses and will include specific work with faith and ethnic groups, experts on physical and learning disabilities and with LGBT+ communities on their specific concerns about screening, with a particular focus on the transgender community.</p><p>The Government awaits the final recommendations which will be reported in the summer 2019, and will consider these carefully, alongside the recommendations from the recent reports published by the Public Accounts Committee, the National Audit Office's investigation into screening and the national Cancer Strategy.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 15:43:04 answering member 4455 label Biography information for Seema Kennedy
	tabling member	252 label Biography information for Dr David Drew

1129997

	registered interest
	date	05/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he plans to clarify governance arrangements for cancer screening between the NHS, Public Health England and his Department.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	260534
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>Officials from the Department and Public Health England have engaged with Professor Sir Mike Richards to ensure that his ongoing review gives consideration to the governance of all screening programmes.</p><p>The Terms of Reference for Professor Sir Mike Richards' Review include making recommendations, if needed, on how NHS England interacts with Public Health England and the Department to translate screening policy into implementation and on how screening programmes should be commissioned, delivered, performance managed and quality assured in the future.</p><p>Professor Sir Mike Richards published an interim report on 24 May on his emerging findings of the independent review of national screening programmes in England. However, the Government awaits the final recommendations which will be reported in summer 2019, and will consider these carefully, alongside the recommendations from the recent reports published by the Public Accounts Committee, the National Audit Office's investigation into screening and the national Cancer Strategy.</p><p>The findings of the review will be taken forward as part of the NHS Long Term Plan.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 16:13:33 answering member 4455 label Biography information for Seema Kennedy
	tabling member	252 label Biography information for Dr David Drew

1130086

	registered interest
	date	05/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Opioids: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the quality of care and therapy provision for people with opioid addiction.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	260568
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>The Care Quality Commission (CQC) routinely carries out reviews of substance misuse services. In their most recent assessment the CQC rated the majority of residential substance misuse centres and community substance misuse centres as good or outstanding.</p><p>Public Health England (PHE) has published a comprehensive review of the evidence on the drug misuse treatment system in England. In comparison with other countries and the international research, it shows the system is performing well but there are some areas where we can improve. Although the review covers drug treatment effectiveness, it does not address the quality of care and therapy. The review is available to view at the following link:</p><p><a href="https://www.gov.uk/government/publications/drug-misuse-treatment-in-england-evidence-review-of-outcomes" target="_blank">https://www.gov.uk/government/publications/drug-misuse-treatment-in-england-evidence-review-of-outcomes</a></p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 16:11:01 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1436 label Biography information for Paul Farrelly

1128389

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Allergies: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the availability of epinephrine auto injectors for children in (a) Wakefield and (b) England.
	tabling member constituency	Morley and Outwood
	tabling member printed	Andrea Jenkyns
	uin	257594
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>Supplies of all paediatric epinephrine auto-injectors are currently available in volumes that are sufficient to meet normal United Kingdom demand. The Department does not hold information about the volume available in Wakefield. All patients who require an epinephrine (adrenaline) auto-injector should now be able to obtain a device from their pharmacy. The Department continues to work very closely with all the manufacturers of epinephrine auto-injectors and can confirm that the supply situation continues to improve.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:32:17 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4490 label Biography information for Dame Andrea Jenkyns

1129645

	registered interest
	date	04/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Haematological Cancer: Mental Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure blood cancer patients receive adequate emotional and psychological support during their treatment.
	tabling member constituency	Livingston
	tabling member printed	Hannah Bardell
	uin	260067
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>In line with the NHS Long Term Plan, by 2021 every cancer patient will be offered personalised care and support planning, based on a holistic needs assessment, done in conjunction with the patient and in accordance with the NHS England Comprehensive Personalised Care model. This will be offered whether the person is due to undergo treatment or not, and includes all patients with blood cancer.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 16:12:19 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4486 label Biography information for Hannah Bardell